PH10129A - Pyrimidinones and hydroxy pyrimidines - Google Patents

Pyrimidinones and hydroxy pyrimidines

Info

Publication number
PH10129A
PH10129A PH13959A PH13959A PH10129A PH 10129 A PH10129 A PH 10129A PH 13959 A PH13959 A PH 13959A PH 13959 A PH13959 A PH 13959A PH 10129 A PH10129 A PH 10129A
Authority
PH
Philippines
Prior art keywords
pyrimidinones
hydroxy pyrimidines
pyrimidines
hydroxy
Prior art date
Application number
PH13959A
Other languages
English (en)
Inventor
G Deangelis
H Ernst
C Lipinski
J Stam
Original Assignee
G Deangelis
H Ernst
C Lipinski
J Stam
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by G Deangelis, H Ernst, C Lipinski, J Stam filed Critical G Deangelis
Publication of PH10129A publication Critical patent/PH10129A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/56—One oxygen atom and one sulfur atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52—Two oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/60—Three or more oxygen or sulfur atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
PH13959A 1971-10-29 1972-10-02 Pyrimidinones and hydroxy pyrimidines PH10129A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US19400671A 1971-10-29 1971-10-29

Publications (1)

Publication Number Publication Date
PH10129A true PH10129A (en) 1976-09-02

Family

ID=22715935

Family Applications (2)

Application Number Title Priority Date Filing Date
PH13959A PH10129A (en) 1971-10-29 1972-10-02 Pyrimidinones and hydroxy pyrimidines
PH17784A PH11594A (en) 1971-10-29 1975-11-21 Pharmaceutical compositions containing pyrimidinones and method of treating gastric hyperacidity

Family Applications After (1)

Application Number Title Priority Date Filing Date
PH17784A PH11594A (en) 1971-10-29 1975-11-21 Pharmaceutical compositions containing pyrimidinones and method of treating gastric hyperacidity

Country Status (25)

Country Link
JP (2) JPS5337870B2 (sv)
AR (2) AR198798A1 (sv)
AT (2) AT320656B (sv)
AU (1) AU467600B2 (sv)
BE (1) BE790125A (sv)
CA (1) CA980778A (sv)
CH (2) CH549579A (sv)
DE (3) DE2264657C2 (sv)
DK (1) DK131465B (sv)
EG (1) EG11013A (sv)
ES (2) ES407730A1 (sv)
FI (1) FI55503C (sv)
FR (1) FR2157865B1 (sv)
GB (2) GB1377308A (sv)
IE (1) IE37043B1 (sv)
IL (2) IL40458A (sv)
LU (1) LU66304A1 (sv)
NL (1) NL166470C (sv)
NO (1) NO136574C (sv)
PH (2) PH10129A (sv)
PL (2) PL84634B1 (sv)
SE (2) SE393376B (sv)
SU (2) SU498908A3 (sv)
YU (2) YU35125B (sv)
ZA (1) ZA727362B (sv)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS55151912U (sv) * 1979-04-17 1980-11-01
JPS5752409Y2 (sv) * 1979-11-05 1982-11-15
DE3222914A1 (de) * 1982-06-18 1983-12-22 Beiersdorf Ag, 2000 Hamburg Substituierte 5-phenylthio-6-amino-pyrimidinone, verfahren zu ihrer herstellung und ihre verwendung sowie diese verbindungen enthaltende zubereitungen
JPH0655686B2 (ja) * 1988-08-30 1994-07-27 宇部興産株式会社 ｐ−ブロモフェノキシアセトアルデヒドジアルキルアセタール類の製造方法
US7776870B2 (en) 2005-08-22 2010-08-17 Melior Pharmaceuticals I, Inc. Methods for modulating Lyn kinase activity and treating related disorders
US8552184B2 (en) 2008-07-03 2013-10-08 Melior Pharmaceuticals I, Inc. Compounds and methods for treating disorders related to glucose metabolism
WO2011150300A1 (en) 2010-05-28 2011-12-01 Melior Pharmaceuticals I, Inc. Prevention of pancreatic beta cell degeneration
BR112019021140A2 (pt) 2017-04-10 2020-05-19 Univ Louisiana State composição, método para reduzir os níveis de glicose no sangue, ganho de peso ou níveis de depósito de gordura, ou tratamento, método de indução do bege de adipócitos ou prevenção da degeneração das células beta do pâncreas, e, ativador de lyn cinase e agonista de trpm8 para uso na redução dos níveis de glicose no sangue, ganho de peso ou níveis de depósito de gordura, ou tratamento.

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2913462A (en) * 1959-11-17 Eahl h
GB951431A (en) * 1959-03-17 1964-03-04 Wellcome Found Pyrimidine derivatives and the manufacture thereof

Also Published As

Publication number Publication date
IL48790A0 (en) 1976-03-31
CH555832A (fr) 1974-11-15
AR198798A1 (es) 1974-07-24
NL7213959A (sv) 1973-05-02
PH11594A (en) 1978-03-31
ES407730A1 (es) 1976-01-16
YU36295B (en) 1982-06-18
JPS4852780A (sv) 1973-07-24
SE397090B (sv) 1977-10-17
FI55503B (fi) 1979-04-30
YU99179A (en) 1981-08-31
FI55503C (fi) 1979-08-10
AR196263A1 (es) 1973-12-10
FR2157865A1 (sv) 1973-06-08
CH549579A (fr) 1974-05-31
DK131465B (da) 1975-07-21
IE37043L (en) 1973-04-29
DE2264374A1 (de) 1973-05-24
SE393376B (sv) 1977-05-09
JPS5337870B2 (sv) 1978-10-12
NO136574C (no) 1977-09-28
YU35125B (en) 1980-09-25
ZA727362B (en) 1973-11-28
AT321308B (de) 1975-03-25
FR2157865B1 (sv) 1975-10-31
AU4722872A (en) 1974-04-04
BE790125A (fr) 1973-04-16
JPS5422995B2 (sv) 1979-08-10
YU255172A (en) 1980-03-15
DK131465C (sv) 1975-12-08
SE7505279L (sv) 1975-05-06
EG11013A (en) 1976-11-30
NL166470B (nl) 1981-03-16
SU498908A3 (ru) 1976-01-05
IE37043B1 (en) 1977-04-27
JPS53116386A (en) 1978-10-11
DE2248741A1 (de) 1973-05-03
DE2248741C3 (de) 1975-06-26
ES436624A1 (es) 1977-02-01
LU66304A1 (sv) 1973-05-03
DE2264374C3 (de) 1981-07-23
AT320656B (de) 1975-02-25
IL40458A (en) 1976-05-31
DE2264657A1 (de) 1974-06-20
NL166470C (nl) 1981-08-17
CA980778A (en) 1975-12-30
NO136574B (sv) 1977-06-20
GB1377308A (en) 1974-12-11
DE2264657C2 (de) 1982-09-16
GB1377720A (en) 1974-12-18
IL40458A0 (en) 1972-11-28
IL48790A (en) 1976-05-31
DE2248741B2 (de) 1974-11-14
DE2264374B2 (de) 1980-08-07
PL89852B1 (sv) 1976-12-31
PL84634B1 (sv) 1976-04-30
SU505362A3 (ru) 1976-02-28
AU467600B2 (en) 1975-12-04

Similar Documents

Publication Publication Date Title
IL38887A (en) Seats and the like
PH10129A (en) Pyrimidinones and hydroxy pyrimidines
IE35376B1 (en) Pyrimidine derivatives
JPS5598103A (en) Novel quinazolinone herbicide
MY7600125A (en) Novel pyrimidine sulphamates their preparation and use
ZA726099B (en) Isopropylamino pyrimidine derivatives
GB1389466A (en) Door retainer
ZA715366B (en) Substituted uracils
IL37565A0 (en) 6-(4-oxopentyl)-tetrahydropyranes and their preparation
AU4493472A (en) 2-nitroamino-6-hydroxy-4-methyl pyrimidines
ZA739661B (en) New pyrimidines
IL39354A0 (en) 2,5-bis-substituted pyrimidines and their preparation
PH9305A (en) Trialkoxy quinazolines
CA860327A (en) Arabinofuranosyl pyrimidines
CA860328A (en) Arabinofuranosyl pyrimidines
CA831985A (en) 2-methoxy-4-(n4-glutarylsulfanilamido) quinazoline
AU458379B2 (en) Trialkoxy quinazolines
AU3531771A (en) Insect-screen doors and the like
ZA713822B (en) Building module and building construction
AU2783271A (en) Trialkoxy quinazolines
IE30931L (en) Marble-faced panels and tiles
CA887647A (en) 2-amino pyrimidines and their production
CA962272A (en) Pyrimidinones
AU477979B2 (en) Quinazolinones
CA845721A (en) Chloropyrimidines